When Hair Shedding Needs a Doctor, Not a Supplement

By Dr. Susan Lin, MD | MD HAIR | La Cañada Ventures, Inc.
Published on mdhair.com — Hormonal & Life Stage Hair Loss Series

There is a version of this that I see far too often, and it goes like this.

Something changes. The shedding gets worse, or a patch appears, or the scalp starts to hurt in a way scalps are not supposed to hurt. And instead of a phone call to a doctor, there is an order. A serum, a supplement, a scalp oil with good reviews — because a purchase is available at eleven at night and an appointment is not, and because buying something feels like acting. Three months later, a second order, from a different brand, because the first one did not work.

And somewhere in those months, a condition that had a window closed it.

I formulate and sell hair products. I am telling you this anyway, because a proportion of the people reading this page do not need a product, and telling them otherwise would be the cheapest thing I could do. Some hair loss is a dermatological or medical problem, and the only correct first step is an appointment. This article is about how to tell whether you are in that group.

The Distinction That Matters

Most hair shedding in adults falls into two broad categories that are neither emergencies nor mysteries: a telogen effluvium, a synchronized shed following a systemic trigger by two to four months, which resolves when its cause is corrected; and androgenetic (pattern) hair loss, gradual, patterned miniaturization at the part and crown. Both benefit from evaluation. Neither is urgent in the sense that a week matters.

Then there is a third category, and it behaves differently. It includes conditions in which the follicle is being actively destroyed, conditions where hair loss is the visible edge of a systemic disease, and conditions where an infection or an inflammatory process is doing damage that accumulates.

The distinguishing feature of the third category is that time costs you something permanent. That is the entire reason this article exists.

Red Flags: Go and Be Seen

If any of the following describes you, the next step is a physician — your primary care doctor or a dermatologist — and not a purchase.

1. Sudden onset, over days rather than months

Hair loss that appears over days to a couple of weeks is behaving differently from an ordinary shed, which builds over weeks and follows its trigger by months. Abrupt loss, and particularly loss of large amounts of hair that come away with minimal force, warrants prompt assessment.

2. Patchy loss rather than diffuse thinning

Discrete round or oval bald patches with otherwise normal-looking skin are the classic presentation of alopecia areata, an autoimmune condition in which the immune system attacks the hair follicle. It is not caused by stress alone, it is not a nutritional problem, and it has real medical treatments — the therapeutic landscape has changed substantially in recent years (Pratt et al., 2017). A supplement is not the answer to this and delay is not free.

Patchy loss in a child, or patches with broken-off stubbly hairs and scaling, raises tinea capitis — a fungal infection that requires oral antifungal treatment, because topical agents do not reliably penetrate the hair shaft (Ely et al., 2014). It is contagious, and untreated it can scar.

3. Scalp pain, burning, tenderness, redness, pustules, or persistent scaling

An uncomfortable scalp is not a normal feature of pattern hair loss or of a simple shed. Pain, burning or persistent tenderness — especially localised — is a signal of active inflammation at the follicle. Pustules suggest folliculitis or a more destructive process. Persistent thick scaling with hair loss can indicate scalp psoriasis, severe seborrhoeic dermatitis, discoid lupus or a fungal infection, and these are distinguished by examination rather than by guesswork.

Scalp itch or pain accompanied by hair loss is the combination that most reliably means see someone. Either alone is common; together they change the assessment.

4. A smooth, shiny patch where the pore openings have disappeared

This is the one I most want you to recognise, and it is genuinely visible to a careful observer.

Look closely at the affected skin, ideally with a magnifier and good light. On normal scalp — even severely thinned scalp — you can see follicular openings: tiny pores, often with a fine hair or the stub of one emerging. In scarring (cicatricial) alopecia, the follicle has been replaced by fibrous tissue, and those openings are gone. The skin looks smooth, shiny, sometimes slightly pale or waxy, sometimes with a subtle change in colour, and it is featureless where it should be pitted.

That appearance means follicles have been permanently destroyed, and the hair in that area will not return. What treatment can do is arrest the process at its active margin and protect the hair that remains. That is why the primary cicatricial alopecias — lichen planopilaris, frontal fibrosing alopecia, discoid lupus erythematosus, central centrifugal cicatricial alopecia, folliculitis decalvans — are managed as conditions requiring prompt specialist attention rather than watchful waiting (Olsen et al., 2003; Harries et al., 2008).

If you see a smooth shiny area without visible pores, particularly with any accompanying redness, scale at the follicle margins, itch, burning or pain, make a dermatology appointment and say those words when you book. Do not wait to see whether it grows back. Whether it grows back is not the question the appointment is answering; whether it spreads is.

Frontal fibrosing alopecia deserves a specific mention because it is under-recognised and increasingly common in postmenopausal women: a band of recession along the frontal hairline, often with loss of the eyebrows, and often mistaken for ordinary hairline thinning or traction for years before it is diagnosed.

5. Shedding alongside fatigue, weight change, mood change, or menstrual change

Hair is metabolically expensive and non-essential, so the follicle is among the first tissues the body deprioritises when something systemic is wrong. Hair loss occurring together with fatigue, unexplained weight gain or loss, cold or heat intolerance, low mood, palpitations, new irregular periods, new facial hair or acne, joint pain or a facial rash is not a hair problem. It is a systemic problem with a hair sign, and the correct response is a medical evaluation of the whole picture.

Thyroid disease in either direction, iron deficiency, coeliac disease, polycystic ovary syndrome, systemic lupus erythematosus and significant nutritional deficiency all present this way.

6. Hair loss after starting a new medication

A great many drugs can cause hair shedding, and it is regularly missed because the loss begins two to three months after the drug was started — by which time nobody connects them. The categories worth flagging to your prescriber include anticoagulants, some antihypertensives including beta blockers, retinoids, some antidepressants and mood stabilizers, hormonal contraceptives and hormone therapy changes, some anticonvulsants, and chemotherapeutic agents.

Take this to the prescriber, not to the internet, and do not stop anything on your own. Some of these drugs are doing something more important than your hair, and the decision is a clinical one about trade-offs.

7. Anything in a child

Hair loss in children is a different specialty with a different differential — tinea capitis, alopecia areata, trichotillomania, nutritional and endocrine causes. It should be assessed medically, not treated cosmetically.

The Labs Worth Asking For

If you are going in, go in with a list. These are the tests that most often change the answer in an adult with diffuse shedding, and several are routinely omitted.

  • Full thyroid panel — TSH plus free T4, and free T3 and thyroid peroxidase antibodies where autoimmune thyroid disease is suspected. TSH alone is a screening test, not a complete picture.
  • Serum ferritin — not haemoglobin, and not iron. Ferritin reflects storage iron, and the follicle registers depletion long before anaemia appears. Ask for the number, not just normal: the laboratory's lower limit is set for haematological purposes, and the thresholds discussed in the hair literature are considerably higher (Trost et al., 2006). Note also that ferritin is an acute-phase reactant and rises with inflammation, so a normal-looking ferritin during illness can be falsely reassuring.
  • Complete blood count — to place the ferritin in context.
  • Serum 25-hydroxyvitamin D.
  • Zinc, where the history suggests malabsorption, restrictive diets or bariatric surgery.
  • Coeliac serology where there are gastrointestinal symptoms, iron deficiency that will not correct, or a family history.
  • Androgen panel — total and free testosterone, DHEA-S, and where indicated 17-hydroxyprogesterone — if there is hirsutism, acne, or menstrual irregularity.
  • Prolactin, where periods have stopped or become irregular.
  • ANA, where there is a rash, photosensitivity, joint pain or a suspicion of lupus.

One practical note that belongs in this list: high-dose biotin supplements can interfere with laboratory immunoassays, including thyroid function tests and troponin, producing spurious results (Patel et al., 2017; FDA). Interference is generally described from around 5 mg upward, which is a dose commonly found in hair supplements. If you are taking one, tell the phlebotomist and your physician, and be prepared to stop it for several days before testing. It is one of the reasons I formulate biotin at a cofactor dose rather than a megadose.

What the Visit Actually Involves

I want to remove some of the intimidation, because avoidance is often about not knowing what will happen.

A hair and scalp consultation is short, non-invasive and mostly conversation. Expect a history — when it started, how fast, what else changed, what you take, family history, styling practices, menstrual and obstetric history. Expect an examination of the whole scalp under good light, including the back and sides, which is how diffuse loss is distinguished from patterned loss. Expect a pull test, done in several zones (Dhurat & Saraogi, 2009). Expect dermoscopy, or trichoscopy — a handheld magnifier with a light, placed on the scalp, which lets the clinician see follicular openings, calibre variability and perifollicular changes directly, and which is painless and takes a minute (Miteva & Tosti, 2012).

A scalp biopsy is sometimes needed, principally when a scarring alopecia is suspected and the diagnosis will determine treatment. It is a small punch of skin taken under local anaesthetic from the active edge of the affected area, usually 4 mm, with a stitch or two. It is a minor procedure done in the room. If it is offered for a suspected cicatricial alopecia, it is worth having — the treatments for the different scarring alopecias differ, and getting it right matters when the alternative is continued destruction.

The Bottom Line

Most shedding is a shed, and most gradual thinning is pattern loss, and both deserve evaluation without alarm. But a specific set of findings means the correct next step is a doctor rather than a purchase: sudden onset over days; patchy rather than diffuse loss; scalp pain, redness, pustules or persistent scaling; a smooth shiny patch where the follicular openings have disappeared; shedding accompanied by fatigue, weight, mood or menstrual change; hair loss after a new medication; and anything at all in a child.

The smooth shiny patch is the one to memorise. Scarring alopecia destroys follicles permanently, and treatment protects the margin rather than restoring the centre — which makes it the one situation in this field where a few months genuinely matters.

Go with a list. Ask for a full thyroid panel, ferritin with the actual number, vitamin D, a complete blood count, and an androgen panel if there are other androgenic signs. Mention any biotin you take before you have blood drawn.

And if what you find is that it is a straightforward shed or straightforward pattern loss — that is a good outcome, arrived at properly, and everything else you might do afterwards will work better for your having established it first.

Dr. Susan Lin's Clinical Perspective

"I sell hair products, and I am telling you not to buy one. That is not modesty; it is sequencing. The most expensive mistake in this field is not choosing the wrong bottle — it is spending nine months choosing bottles while an inflammatory or autoimmune process closes a window that does not reopen. A smooth shiny patch with no visible pores is the finding I would want every reader to be able to recognise, because it means follicles have been replaced by scar and the only remaining question is how much of the surrounding scalp we can protect. My rule is simple and I apply it in my own practice: pain, patches, pustules, persistent scaling, a smooth shiny area, or hair loss with systemic symptoms — that is a physician, promptly, and nothing goes in a basket until someone has looked."

— Dr. Susan F. Lin, M.D., Physician Formulator, MD HAIR

Mechanism Spotlight: Why Scarring Alopecia Is Permanent and Ordinary Thinning Is Not

The difference between hair loss you can influence and hair loss you cannot comes down to a small population of cells in a specific part of the follicle.

The follicle regenerates itself every cycle from a reservoir of stem cells housed in the bulge, a region of the outer root sheath at the level of the arrector pili muscle insertion. At the end of telogen, signals from the dermal papilla activate bulge stem cells, which proliferate and rebuild the entire lower follicle for a new anagen phase. This is why a follicle can shrink dramatically in pattern hair loss and still be recoverable: the miniaturized follicle retains its bulge, and therefore retains the capacity to build a larger structure again if the signalling environment changes.

The primary cicatricial alopecias are defined by a different target. In these conditions a lymphocytic or neutrophilic inflammatory infiltrate concentrates at the level of the isthmus and the bulge, and the stem cell reservoir itself is destroyed and replaced by fibrous tissue. Sebaceous glands are typically lost early, which is one of the histological hallmarks. Once the bulge is gone there is no template from which the follicle can regenerate, and the follicular opening closes over — producing the smooth, shiny, pore-less surface that is visible to the naked eye and that defines the clinical category (Olsen et al., 2003).

This is why the therapeutic goal in cicatricial alopecia is arrest rather than regrowth, and why treatment is directed at the inflamed active margin rather than at the burnt-out centre (Harries et al., 2008). It is also why the clinical urgency is real in a way it is not for pattern loss: every month of uncontrolled inflammation converts a further band of recoverable follicles into scar. Recognising the smooth patch early is not a matter of restoring what is gone. It is a matter of how much of the rest is still there when treatment starts.

Recommended Reading

Pillar pages on mdhair.com:

Related articles in this series:

Our sister site md-factor.com publishes the same documentation and disclosure standards across the wider MD® portfolio.

MD HAIR Product Recommendation

None. This article's whole argument is that a proportion of readers need an appointment rather than a purchase, and following it with a product recommendation would quietly undo the argument. If you recognised yourself in the red flags above, the thing you need is a doctor's assessment, and nothing I make substitutes for one.

One link instead, and it is the one that belongs before any spending decision:

The MD HAIR Quiz — a structured way to organize what you are actually observing, so that you walk into an appointment with a clear history rather than an impression. It is a starting point for reasoning, not a diagnosis. For a diagnosis, see your own physician, and take the lab list above with you.

To be explicit, because it is the point of the page: a physician comes before a product. MD® products are cosmetics and dietary supplements. They support a healthy scalp environment. They do not treat seborrhoeic dermatitis, psoriasis, scarring alopecia, alopecia areata, fungal infection, thyroid disease or iron deficiency, and no cosmetic or supplement should be represented as doing so — including mine.

A note on authenticity: genuine MD HAIR™ and MD Nutri Hair™ products are sold only through mdhair.com, md-factor.com, and the official La Cañada Ventures, Inc. stores on Amazon and Walmart. We cannot verify the storage, handling, labelling or lot integrity of units bought anywhere else.

References

  1. Olsen EA, Bergfeld WF, Cotsarelis G, et al. (2003). Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia. Journal of the American Academy of Dermatology, 48(1), 103–110. PMID 12522378
  2. Harries MJ, Sinclair RD, Macdonald-Hull S, Whiting DA, Griffiths CEM, Paus R. (2008). Management of primary cicatricial alopecias: options for treatment. British Journal of Dermatology, 159(1), 1–22. PMID 18489608
  3. Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. (2017). Alopecia areata. Nature Reviews Disease Primers, 3, 17011. PMID 28300084
  4. Ely JW, Rosenfeld S, Seabury Stone M. (2014). Diagnosis and management of tinea infections. American Family Physician, 90(10), 702–710. PMID 25403034
  5. Miteva M, Tosti A. (2012). Hair and scalp dermatoscopy. Journal of the American Academy of Dermatology, 67(5), 1040–1048. PMID 22405573
  6. Dhurat R, Saraogi P. (2009). Hair evaluation methods: merits and demerits. International Journal of Trichology, 1(2), 108–119. PMID 20927232
  7. Trost LB, Bergfeld WF, Calogeras E. (2006). The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. Journal of the American Academy of Dermatology, 54(5), 824–844. PMID 16635664
  8. Grover C, Khurana A. (2013). Telogen effluvium. Indian Journal of Dermatology, Venereology and Leprology, 79(5), 591–603. PMID 23974577
  9. Patel DP, Swink SM, Castelo-Soccio L. (2017). A review of the use of biotin for hair loss. Skin Appendage Disorders, 3(3), 166–169. PMID 28879195
  10. U.S. Food and Drug Administration. Biotin Interference with Troponin Lab Tests — Assays Subject to Biotin Interference. fda.gov

Dr. Susan F. Lin, M.D. is the physician formulator behind MD HAIR and MD Nutri Hair™, product lines of La Cañada Ventures, Inc. — physician-formulated since 2008 under the MD® mark (U.S. Reg. No. 4,471,494). She trained at Boston University School of Medicine and is board-certified in Obstetrics & Gynecology and in Anti-Aging Medicine (A4M).

MD® products are cosmetics and dietary supplements manufactured in FDA-registered, GMP-compliant facilities. "FDA-registered" describes the facility, not the product: MD® products are not FDA approved, and no cosmetic or dietary supplement is. Individual results vary. MD Nutri Hair™ is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Because there are no clinical data in pregnant or breastfeeding women, we do not advocate using MD HAIR products during pregnancy or lactation.

This article is for educational purposes and does not constitute medical advice. It is not a substitute for examination by a qualified clinician, and the red flags described here are guidance for seeking care rather than criteria for self-diagnosis. Consult your own physician or a dermatologist, and do not start, stop, or change any medication without consulting your prescriber.

Explore more in our Hormonal & Life Stage Hair Loss series at mdhair.com/pages/hormonal-hair-loss